Barinthus Biotherapeutics plc (ADR)
General ticker "BRNS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $43.2M (TTM average)
Barinthus Biotherapeutics plc (ADR) follows the US Stock Market performance with the rate: 0.8%.
Estimated limits based on current volatility of 5.8%: low 0.54$, high 0.61$
Factors to consider:
- Total employees count: 130 as of 2023
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.49$, 1.47$]
- 2026-12-31 to 2027-12-31 estimated range: [0.55$, 1.57$]
Short-term BRNS quotes
Long-term BRNS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.80MM | $14.97MM | $0.00MM |
| Operating Expenses | $84.72MM | $82.94MM | $54.19MM |
| Operating Income | $-83.91MM | $-67.97MM | $-54.19MM |
| Non-Operating Income | $7.39MM | $6.74MM | $-14.60MM |
| Interest Expense | $0.03MM | $0.05MM | $0.05MM |
| R&D Expense | $41.41MM | $38.25MM | $25.56MM |
| Income(Loss) | $-76.52MM | $-61.23MM | $-68.79MM |
| Taxes | $-3.08MM | $-0.04MM | $-0.20MM |
| Profit(Loss)* | $-73.35MM | $-61.07MM | $-66.43MM |
| Stockholders Equity | $186.78MM | $130.03MM | $74.21MM |
| Assets | $214.51MM | $160.33MM | $98.17MM |
| Operating Cash Flow | $-50.92MM | $-28.94MM | $-47.98MM |
| Capital expenditure | $5.41MM | $0.89MM | $0.04MM |
| Investing Cash Flow | $-5.41MM | $-0.89MM | $0.42MM |
| Financing Cash Flow | $1.87MM | $2.16MM | $0.00MM |
| Earnings Per Share** | $-1.91 | $-1.55 | $-1.64 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.